Log in to MyACC
- CMS Current Emergencies website
- April 6 Dear Clinician Letter
- Physician and Other Practitioner Waiver Fact Sheet
- April 6 Non-Emergent Services Recommendations
- General Telehealth and Telemedicine Tool Kit
- Extension of Quality Program Deadlines
- Comprehensive list of Coronavirus Waivers & Flexibilities
- What You Need to Know: Considerations For Reopening and Non-COVID-19 Care
- Feature | Key Questions on COVID-19 and Cardiovascular Disease
- Hydroxychloroquine With or Without Macrolide: Harm, No Benefit Found in Multinational Registry
- Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19
- FDA Drug Safety Announcement Cautions Against Use of Hydroxychloroquine, Chloroquine in COVID-19
- Remdesivir: Published Preliminary Results Show Shorter Recovery in COVID-19 Patients
- The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Treatment Trial (ACCT-1): On Solid Ethical and Scientific Grounds
- Is Remdesivir a Potential COVID-19 Treatment?
- False-Negative Rate of RT-PCR SARS-CoV-2 Tests
